HDMA said Monday that Miller has been named senior director of regulatory affairs, a new position. She will be responsible for recommending policies and positions on federal regulatory proposals, focusing with a primarily on proposals related to the Drug Enforcement Administration (DEA).
In addition, Miller will facilitate and coordinate HDMA members’ efforts to implement federal regulations, the association said.
Previously, Miller served as an attorney in the DEA’s Diversion & Regulatory Policy Section, where she advised on the regulation of controlled substances and listed chemicals throughout the pharmaceutical supply chain, among other responsibilities. She also served as senior counsel for the U.S. Pharmacopeia (USP) and as an associate in the food and drug practice of Covington & Burling LLP.
“Ruth brings significant health care policy and advocacy experience to our expanded regulatory affairs team,” HDMA president and chief executive officer John Gray said in a statement. “Her background and knowledge will be invaluable to HDMA and our industry as we continue to address prescription drug abuse in the U.S. and work to strengthen our partnership with the DEA.”